Agilent’s Thought Leader Award Supports Dr. Paul Watkins|
Thursday, January 23, 2014
Dr. Watkins has received the award in recognition of his ongoing work developing integrated methods to predict DILI.
TAP Biosystems Presents New Data on 3D Cell Culture Research
Monday, January 20, 2014
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Scripps' Scientists Develop Promising Drug Candidates for Pain and Addiction
Thursday, January 16, 2014
Two new drug scaffolds offer researchers novel tools that act on the kappa opioid receptor.
World’s Tiniest Drug Cabinets could be Attached to Cancerous Cells for Long Term Treatment
Wednesday, January 15, 2014
Reservoirs of pharmaceuticals could be manufactured to bind specifically to infected tissue such as cancer cells for slow, concentrated delivery of drug treatments.
Selvita Extends Collaboration with Chiesi Farmaceutici
Monday, January 13, 2014
Collaboration started with fee-for-service chemical synthesis in 2011.
Adocia Launches Phase IIa Clinical Trial for its Ultra-fast Acting Formulation of Analog Insulin
Tuesday, January 07, 2014
The aim is to confirm on type I diabetic patients the positive results obtained during phase I.
Cyprotex Acquires CeeTox
Thursday, January 02, 2014
Auquistion broadens toxicological assay and screening capabilities to the cosmetic and personal care industry.
Galapagos Selects Pre-Clinical Candidate for Cystic Fibrosis
Tuesday, December 17, 2013
Start of Phase 1 expected before end 2014.
Evotec Receives Pre-Clinical Milestone with Boehringer Ingelheim
Tuesday, December 10, 2013
The milestone relates to the transition of an oncology molecule into pre-clinical development.